Literature DB >> 10835628

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.

M J Karkkainen1, R E Ferrell, E C Lawrence, M A Kimak, K L Levinson, M A McTigue, K Alitalo, D N Finegold.   

Abstract

Primary lymphoedema is a rare, autosomal dominant disorder that leads to a disabling and disfiguring swelling of the extremities and, when untreated, tends to worsen with time. Here we link primary human lymphoedema to the FLT4 locus, encoding vascular endothelial growth factor receptor-3 (VEGFR-3), in several families. All disease-associated alleles analysed had missense mutations and encoded proteins with an inactive tyrosine kinase, preventing downstream gene activation. Our study establishes that VEGFR-3 is important for normal lymphatic vascular function and that mutations interfering with VEGFR-3 signal transduction are a cause of primary lymphoedema.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835628     DOI: 10.1038/75997

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  160 in total

1.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.

Authors:  Jeffrey T Wigle; Natasha Harvey; Michael Detmar; Irina Lagutina; Gerard Grosveld; Michael D Gunn; David G Jackson; Guillermo Oliver
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

2.  GJC2 missense mutations cause human lymphedema.

Authors:  Robert E Ferrell; Catherine J Baty; Mark A Kimak; Jenny M Karlsson; Elizabeth C Lawrence; Marlise Franke-Snyder; Stephen D Meriney; Eleanor Feingold; David N Finegold
Journal:  Am J Hum Genet       Date:  2010-05-27       Impact factor: 11.025

Review 3.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

4.  Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor.

Authors:  Tatiana V Petrova; Taija Mäkinen; Tomi P Mäkelä; Janna Saarela; Ismo Virtanen; Robert E Ferrell; David N Finegold; Dontscho Kerjaschki; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

5.  Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.

Authors:  Jan Kazenwadel; Genevieve A Secker; Yajuan J Liu; Jill A Rosenfeld; Robert S Wildin; Jennifer Cuellar-Rodriguez; Amy P Hsu; Sarah Dyack; Conrad V Fernandez; Chan-Eng Chong; Milena Babic; Peter G Bardy; Akiko Shimamura; Michael Y Zhang; Tom Walsh; Steven M Holland; Dennis D Hickstein; Marshall S Horwitz; Christopher N Hahn; Hamish S Scott; Natasha L Harvey
Journal:  Blood       Date:  2011-12-06       Impact factor: 22.113

Review 6.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

7.  Possible genetic predisposition to lymphedema after breast cancer.

Authors:  Beth Newman; Felicity Lose; Mary-Anne Kedda; Mathias Francois; Kaltin Ferguson; Monika Janda; Patsy Yates; Amanda B Spurdle; Sandra C Hayes
Journal:  Lymphat Res Biol       Date:  2012-03-09       Impact factor: 2.589

8.  lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish.

Authors:  Kazuhide S Okuda; Jonathan W Astin; June P Misa; Maria V Flores; Kathryn E Crosier; Philip S Crosier
Journal:  Development       Date:  2012-05-23       Impact factor: 6.868

Review 9.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

10.  Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

Authors:  Megan E Baldwin; Michael M Halford; Sally Roufail; Richard A Williams; Margaret L Hibbs; Dianne Grail; Hajime Kubo; Steven A Stacker; Marc G Achen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.